HRS-9815

N/A

Report date: 2025/11/20 16:00:41

NME

Base Information

Drug NameHRS-9815

Drug Alias NameHRS-9815HRS9815

ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)Radiation-emitting products > Nuclides > Gallium > 68Ga +[4]

Mechanisms of ActionProstate-Specific Membrane Antigen inhibitors

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsDiagnostic agentsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesTianjin Hengrui Pharmaceutical Co Ltd

China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTianjin Hengrui Pharmaceutical Co Ltd Jiangsu Hengrui Medicine Co Ltd

Inactive CompaniesN/A

Active IndicationsDiagnostic agentsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A